Skip to main content
Premium Trial:

Request an Annual Quote

From the Inside

Premium

A new device developed by researchers at MIT is the latest weapon in the cancer-fighting arsenal, says New Scientist's Ferris Jabr. The tiny implantable tool can "track" the growth of a tumor from the inside — it's small enough to fit inside a needle and can be inserted during a regular biopsy, Jabr says. The small capsule is filled with magnetic nanoparticles containing monoclonal antibodies which can bind to molecules that indicate the presence of cancer. Doctors can use an MRI scan to "read" the device and detect the cancer-related molecules inside it, Jabr adds.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.